首頁
Chemist + Druggist

11月 2025Chemist + Druggist的市場佔有率分析

Clinical news articles affecting community pharmacy and pharmacy staff including serious shortage protocols (SSPs)

健康 > 藥房

域名chemistanddruggist.co.uk

成立年份--

僱員51 - 200

年度營收$15M - $25M

Chemist + Druggist

Chemist + Druggist（包含公司地區）

chemistanddruggist.co.uk

查看更多網站流量與參與度資訊

Chemist + Druggist截至 11月 2025 的總收入為 15M - 25M

Chemist + Druggist 熱門網域產生的總收入

Chemist + Druggist 熱門網域 3 年內的總收入

Chemist + Druggist 熱門網域的總收入

chemistanddruggist.co.uk15M - 25M

透過銷售情報查看更多內容

Chemist + Druggist的熱門網域總造訪量

了解Chemist + Druggist市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

chemistanddruggist.co.uk49.8K

透過銷售情報查看更多內容

Chemist + Druggist的熱門網域平均造訪時長

分析Chemist + Druggist參與度指標。

過去 3 個月平均造訪時長

子公司細目

chemistanddruggist.co.uk00:01:09

透過銷售情報查看更多內容

Chemist + Druggist的熱門網域平均頁面瀏覽量

了解Chemist + Druggist如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

chemistanddruggist.co.uk1.94

透過銷售情報查看更多內容

Chemist + Druggist按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

cddata.co.uk公司名C+D Data僱員51 - 200總部英國年度營收$15M - $25M訪問總量--健康 > 藥房

使用的熱門技術Chemist + Druggist

这些是Chemist + Druggist顶级域名使用的行业网站技术

付費廣告 (20)

Google Adsense

轉換與分析 (17)

Google Analytics

付款與貨幣 (12)

Cart Functionality

音訊視訊媒體 (7)

YouTube

更多技術

13

檢視所有

新聞與訊號來自Chemist + Druggist

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Chemistanddruggist launched Salary Survey on Jan 1st '23.Last year, C+D revealed that locums based in Great Britain earned £28.10 per hour on average throughout 2021, the highest rate recorded since C+D launched its annual Salary Survey in 2008.

新聞Chemistanddruggist launches #NoExcuseForAbuse campaign calling for ringfenced funding for security measures in pharmacy.C+D launched a #NoExcuseForAbuse campaign calling for ringfenced funding for security measures in pharmacy, after NHS England announced a £5 million support package for GPs to improve their security measures.

新聞Chemistanddruggist launches Reliviate Aches & Joint Pain Relief 0.5% w/w Gel.With the launch of Reliviate Aches & Joint Pain Relief 0.5% w/w Gel, Chemistanddruggist can now proudly offer consumers this well-established pain relief solution, not previously available without prescription.”